mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.09 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.1 |